Contact the TRICARE Retail Refund Team and FAQs

If you are a new Manufacturer to the TRICARE Retail Refund Program and/or if there are any changes in POC or address for your company you must complete a TRICARE Retail Pharmacy Refund Questionnaire. Each section of the Questionnaire must be completed prior to submitting to UFVARR_requests@mail.mil.  

You must submit a Questionnaire listing you as a POC for every new labeler code you require utilization access to.

A manufacturer may add up to, but no more than, a total of three POCs. The primary POC must be an employee of the manufacturer, the secondary and alternate POCs may be either an employee of the manufacturer or a third party consulting company. If the manufacturer in question has two different POCs on their current Questionnaire, the manufacturer may add one additional POC on the new Questionnaire. 

Download the Questionnaire Now

Yes. Examples of this occurring are when a child needs one inhaler for school and one for home. Patients also may need to get more than one fill if they are going on vacation, lost their medication or the doctor has increased the dosage. It is important to take this into consideration when disputing utilization data.

340b pharmacies are retail pharmacies that may service a variety of patients.  DHA requires that a Manufacturer TRICARE Retail Refund 340b Verification Form be completed by the pharmacy before we are able to accept these disputes. 

Download Operation Documents

From the TRICARE Retail Refund Manufacturer Policy and Procedure Guide, a TRICARE retail pharmacy includes long term care facilities, specialty pharmacies, pharmacies inside a physician's office and hospital, and all other pharmacies identified as part of the TRICARE Retail Network.

It is the responsibility of both parties (the previous manufacturer and new manufacturer) to complete an Appendix A Change Request form in its entirety and submit it to UFVARR_Requests@mail.mil. The form must contain the signatures of both parties. Once the TRICARE Retail Refund Team (TRRT) receives, reviews, and approves the form, billing can be updated. Please note that if the form is submitted with transfer dates in a previous quarter, the transfer will be reflected in the upcoming billing quarter.

If an NDC is reported to the TRRT with a positive minimum refund, it is a covered drug under 38 U.S.C. 8126 of the final rule and eligible for the TRICARE Retail Refund Program. A refund will be owed for covered drugs dispensed through pharmacies identified as part of the TRICARE Retail Network, which includes long term care facilities, specialty pharmacies, and pharmacies inside physician offices or hospitals. In the event that an NDC appears to be incorrectly reported to TRICARE as a covered drug, please contact your POC at the Department of Veterans Affairs. The manufacturer may also submit disputes for these claims (please see the Dispute Submission process in the TRICARE Retail Refund Program Process & Procedures Guide) so that proper credit can be given in the event that the disputes are accepted.

• If an NDC is not included on an ADP Agreement and the pharmaceutical agent is the same for the NDC(s) for which an ADP Agreement is in place, it will be billed under the ADP Program and a discount percentage will be determined based on strength, dosage, and package size of similar NDCs.
• Typically, WAC ADP Agreements will include drugs that are not Covered Drugs, such as diabetes testing supplies. If the NDC is not included on the WAC ADP Agreement for a non-Covered Drug, it will not be billed under WAC, ADP, or SDP. If the NDC of the pharmaceutical agent on the ADP Agreement is a Covered Drug, then it will be billed ADP (FCP or WAC based on the ADP Agreement in place)

If an NDC is not included in a pharmaceutical agent’s ADP Agreement and is eligible to be billed under ADP, the TRRT will calculate the refund owed by assigning the additional percentage from an NDC on the ADP which closely matches this NDC in strength and package size. 

All ADP Agreements for drugs belonging to drug classes reviewed in Pharmaceutical & Therapeutics Committee Meetings will be terminated upon the effective dates determined within the review of each class, regardless of formulary standing. However, if a drug is designated non-formulary per the P&T Committee, a bid that may have been submitted for consideration will not be accepted. ADP Agreements to be terminated will be done so with a termination date determined within each class (not the signing of the minutes unless otherwise indicated). Please refer to the P&T Committee Meeting Minutes for more information.

Although Section 703 Compliant, there are many reasons as to why a drug may not be covered under TRICARE formulary. All formulary questions should be directed to the TRICARE Industry Liaison via email or by calling 1-210-536-6121.

• Verify that your name is listed on a Questionnaire as a POC for the labeler in question.  
• Log into TRRWS (https://trrws.tricare.mil/Public/Login.aspx). 
• Click the “Request Labeler Access” button.
• Request labeler access on TRRWS with the submission of the six digit labeler code including the alpha character (X#####).  
• An email will be sent to the Primary POC and to the TRRT for review.  You will receive an email when your access has been approved.

• Verify that your name is listed on your company’s Questionnaire as a POC.  
• Go to TRRWS (https://trrws.tricare.mil/Public/Login.aspx)
• Select the “Request New User Account” link and complete the form.  A TRICARE Retail Refund Team member will review your request and complete your access. 
• You can only request one (1) labeler for your initial login; additional labeler requests can be submitted once you have access to the site.

An official GovDelivery email will be sent out when data utilization files are released on TRRWS.  

Sign up to Get Email Updates

Report Issue with the TRRWS Website